Forte Biosciences, Inc. (FBRX)
NASDAQ: FBRX · Real-Time Price · USD
32.00
-3.09 (-8.81%)
Apr 13, 2026, 12:18 PM EDT - Market open
Forte Biosciences Market Cap
Forte Biosciences has a market cap or net worth of $600.59 million as of April 13, 2026. Its market cap has increased by 1,045.60% in one year.
Market Cap
600.59M
Enterprise Value
522.31M
1-Year Change
1,045.60%
Ranking
Category
Stock Price
$32.00
Market Cap Chart
Since June 16, 2020, Forte Biosciences's market cap has increased from $181.43M to $600.59M, an increase of 231.02%. That is a compound annual growth rate of 22.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 10, 2026 | 658.58M | 35.44% |
| Dec 31, 2025 | 486.26M | 234.91% |
| Dec 31, 2024 | 145.19M | 386.30% |
| Dec 29, 2023 | 29.86M | 42.17% |
| Dec 30, 2022 | 21.00M | -33.49% |
| Dec 31, 2021 | 31.57M | -93.24% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alto Neuroscience | 727.72M |
| Tenax Therapeutics | 725.58M |
| SpyGlass Pharma | 693.60M |
| Arvinas | 692.06M |
| Gyre Therapeutics | 674.81M |
| BridgeBio Oncology Therapeutics | 672.28M |
| Allogene Therapeutics | 663.08M |
| Alpha Tau Medical | 641.59M |